BioNTech SE ADR closed $8.64 short of its 52-week high ($131.49), which the company achieved on September 17th.

ADR (RLX) stock to Buy rating, as announced on August 8, 2023, according to Finviz. Earlier, on November 1, 2021, BofA Securities had initiated the stock to Neutral, setting a price target of $6.

The Anheuser-Busch InBev S.A. ADR slipped 5.87% to $46.15 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.54% to 5,827.04 and Dow ...

The BP PLC ADR BP inched 0.55% higher to $31.29 Friday, on what proved to be an all-around dismal trading session for the ...

The Anheuser-Busch InBev S.A. ADR slumped 0.39% to $49.03 Wednesday, on what proved to be an all-around favorable trading ...

On Friday, VNET Group Inc – ADR (VNET) stock saw a decline, ending the day at $5.5 which represents a decrease of $-0.26 or -4.51% from the prior close of $5.76. The stock opened at $5.56 and touched ...

Improvement in adenoma detection rate among physicians with a baseline rate of less than 26% was significantly associated ...

The company's next dividend payment will be R00.134 per share, on the back of last year when the company paid a total of R0.38 to shareholders. Calculating the last year's worth of payments shows that ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on IGM Biosciences (IGMS – Research Report) and ...

In a letter to the Luxemburger Wort, Robert Mehlen says his party colleague Fernand Kartheiser should face “harsh ...

In a report released today, Eunice Lee from Bernstein maintained a Hold rating on XPeng, Inc. ADR (XPEV – Research Report), with a price target ...